title: Asian trends in prostate cancer hormone therapy.
abstract: The first Conference on Asian Trends in Prostate Cancer Hormone Therapy was held in September 2001 to serve as a forum for Asian urologists to compare data on prostate cancer and discuss issues regarding the use of hormone therapy. The conference revealed that due to various cultural and philosophical factors, differences exist in prostate cancer management among the Asian countries. In addition, a lack of databases on hormone therapy was exposed in some countries. It was noted that many decisions in the treatment of prostate cancer are influenced by the strategies adopted in Western countries, and that attempts to formulate uniform guidelines for the Asian region have hitherto been unsuccessful. The main findings of the conference are reported in this review.
authors.affiliation: Dept. of Urology, University of Tsukuba, Ibaraki 305-8576, Japan. akazah@md.tsukuba.ac.jp
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Akaza
authors.forename: Seiji
authors.initials: S
authors.lastname: Naito
authors.forename: Christopher
authors.initials: C
authors.lastname: Cheng
authors.forename: Amir
authors.initials: A
authors.lastname: Kaisary
authors.forename: Doddy M
authors.initials: DM
authors.lastname: Soebadi
authors.forename: Rainy
authors.initials: R
authors.lastname: Umbas
authors.forename: Kesavan
authors.initials: K
authors.lastname: Esuvaranathan
authors.forename: Fang-Liu
authors.initials: FL
authors.lastname: Gu
authors.forename: Liqun
authors.initials: L
authors.lastname: Zhou
authors.forename: Sung-Joon
authors.initials: SJ
authors.lastname: Hong
authors.forename: Wun-Jae
authors.initials: WJ
authors.lastname: Kim
authors.forename: Sang Eun
authors.initials: SE
authors.lastname: Lee
authors.forename: Joung-Sik
authors.initials: JS
authors.lastname: Rim
authors.forename: Jae Mann
authors.initials: JM
authors.lastname: Song
authors.forename: Jin Han
authors.initials: JH
authors.lastname: Yoon
authors.forename: Shu-Jen
authors.initials: SJ
authors.lastname: Chang
authors.forename: Chun-Hsiung
authors.initials: CH
authors.lastname: Huang
authors.forename: Chi-Rei
authors.initials: CR
authors.lastname: Yang
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Hirao
authors.forename: Masaru
authors.initials: M
authors.lastname: Murai
authors.forename: Taiji
authors.initials: T
authors.lastname: Tsukamoto
authors.forename: Michiyuki
authors.initials: M
authors.lastname: Usami
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D001208:Asia / Q000453:epidemiology; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008017:Life Expectancy; D008297:Male; D008495:Medical Oncology / Q000639:trends; D009313:National Health Programs; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality; D015996:Survival Rate
chemical_list: D000726:Androgen Antagonists; D004967:Estrogens